Huakang Biomedical Holdings Company Limited (HKG:8622)
Hong Kong · Delayed Price · Currency is HKD 0.3900
+0.0100 (2.63%)
Aug 29, 2025, 3:58 PM HKT
HKG:8622 Market Cap
HKG:8622 has a market cap or net worth of 195.18 million as of August 29, 2025. Its market cap has increased by 195.45% in one year.
Market Cap
195.18M
Enterprise Value
159.52M
Revenue
28.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since December 13, 2018, HKG:8622's market cap has increased from 188.00M to 195.18M, an increase of 3.82%. That is a compound annual growth rate of 0.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 195.18M | 160.00% |
| Dec 31, 2024 | 75.07M | 67.66% |
| Dec 29, 2023 | 44.78M | -41.60% |
| Dec 30, 2022 | 76.68M | -22.70% |
| Dec 31, 2021 | 99.20M | 131.78% |
| Dec 31, 2020 | 42.80M | -20.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 257.13B |
| Hansoh Pharmaceutical Group Company | 216.24B |
| JD Health International | 199.69B |
| Innovent Biologics | 155.86B |
| Sino Biopharmaceutical | 138.43B |
| Akeso | 136.61B |
| WuXi Biologics | 126.35B |
| CSPC Pharmaceutical Group | 107.93B |